Skip to main content

Epidiolex (Prescription Cannabidiol) Utilization Patterns: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
Epidiolex (prescription cannabidiol)
Description

This request assessed utilization patterns for Epidiolex (prescription cannabidiol). This assessment was part of FDA's mission to perform surveillance of cannabidiol-containing products.

The study period includes data from July 1, 2018 to March 31, 2020. This analysis includes two reports:

  • Report 1: We executed this request on IBM® MarketScan® Research Databases on July 22, 2021. This report specifies age groupings of 0-5, 6-10, 11-17, and 18+ years.
  • Report 2: We executed this request on IBM® MarketScan® Research Databases on July 22, 2021. This report specifies age groupings of 0-17 and 18+ years.
Deliverables (2)
Sentinel Query Builder Report: Epidiolex (prescription cannabidiol) Utilization Patterns, Report 1 Sentinel Query Builder Report: Epidiolex (prescription cannabidiol) Utilization Patterns, Report 2
Additional Details
FDA Center
CDER
Time Period
July 1, 2018 – March 31, 2020
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
IBM® MarketScan® Research Databases
Related Links
Sentinel Drug Study: Epidiolex (Prescription Cannabidiol) & Utilization